Insider · CIK 0001326330

Barrett Ronald W

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001326330

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+5,500 sh	—	—	11,750
2026-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2025-06-11	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.7K sh	—	—	11,667
2025-06-11	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+3,750 sh	—	—	6,250
2024-06-26	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,350 sh	—	—	8,350
2024-06-26	JANXJanux Therapeutics, Inc.A Award	Director	AAward	+2,500 sh	—	—	2,500
2023-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2022-06-14	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-09-07	JANXJanux Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-06-10	CONCERT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+10.3K sh	—	—	10,250
2021-06-10	CONCERT PHARMACEUTICALS, INC.A Award	Director	AAward	+5,125 sh	—	—	5,125
2020-06-11	CONCERT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-13	CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-06-14	CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-12-04	CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,539 sh	$4.41	+$15.6K	3,539
2017-12-04	CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,539 sh	$3.79	+$13.4K	7,078
2017-12-04	CONCERT PHARMACEUTICALS, INC.S Sale	Director	SSale	−14.2K sh	$24.70	−$350K	0
2017-12-04	CONCERT PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,539 sh	—	—	0
2017-12-04	CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,539 sh	$2.88	+$10.2K	14,156
2017-12-04	CONCERT PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,539 sh	—	—	0
2017-12-04	CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,539 sh	$3.50	+$12.4K	10,617
2017-12-04	CONCERT PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,539 sh	—	—	0
2017-12-04	CONCERT PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,539 sh	—	—	0
2017-06-15	CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-06-09	CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-11-09	CONCERT PHARMACEUTICALS, INC.S Sale	Director	SSale	−10K sh	$21.90	−$219K	0
2015-11-09	CONCERT PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−17.7K sh	—	—	0
2015-11-09	CONCERT PHARMACEUTICALS, INC.S Sale	Director	SSale	−7,699 sh	$22.75	−$175K	10,000
2015-11-09	CONCERT PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+17.7K sh	$1.13	+$20K	17,699
2015-09-01	XENOPORT INCS Sale	Director, Chief Executive Officer	SSale	−12.5K sh	$7.00	−$87.5K	191,703
2015-07-15	XENOPORT INCS Sale	Director, Chief Executive Officer	SSale	−12.5K sh	$7.20	−$90K	204,203
2015-07-13	XENOPORT INCS Sale	Director, Chief Executive Officer	SSale	−12.5K sh	$7.00	−$87.5K	216,703
2015-06-11	CONCERT PHARMACEUTICALS, INC.Nonstatutory Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-01-20	XENOPORT INCEmployee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+80K sh	—	—	80,000
2015-01-14	XENOPORT INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,697 sh	$9.31	−$43.7K	229,203
2015-01-14	XENOPORT INCRestricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−12.5K sh	—	—	25,000
2015-01-14	XENOPORT INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+12.5K sh	—	—	233,900
2015-01-14	XENOPORT INCEmployee Stock OptionA Award	Director, Chief Executive Officer	AAward	+240K sh	—	—	240,000
2015-01-14	XENOPORT INCRestricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+30K sh	—	—	30,000
2015-01-13	XENOPORT INCRestricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−16.3K sh	—	—	0
2015-01-13	XENOPORT INCRestricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−37.5K sh	—	—	0
2015-01-13	XENOPORT INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−14.1K sh	$8.93	−$126K	221,400
2015-01-13	XENOPORT INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+37.5K sh	—	—	235,492
2015-01-13	XENOPORT INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+16.3K sh	—	—	204,061
2015-01-13	XENOPORT INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−6,069 sh	$8.93	−$54.2K	197,992
2015-01-07	XENOPORT INCEmployee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+57.5K sh	—	—	57,500
2015-01-02	XENOPORT INCIncentive Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−16.5K sh	—	—	0
2015-01-02	XENOPORT INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−34.1K sh	$8.83	−$301K	187,811
2015-01-02	XENOPORT INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−50.2K sh	—	—	0
2015-01-02	XENOPORT INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+16.5K sh	$6.00	+$99K	182,943

Recent filings

Accepted (ET)
Jun 124
Barrett Ronald W0001326330-26-000002
SEC(opens sec.gov)
Jun 134
Barrett Ronald W0001415889-25-017317
SEC(opens sec.gov)
Jun 284
Barrett Ronald W0001415889-24-018439
SEC(opens sec.gov)
Jun 164
Barrett Ronald W0001209191-23-037972
SEC(opens sec.gov)
Jun 164
Barrett Ronald W0001209191-22-037453
SEC(opens sec.gov)
Sep 94
Barrett Ronald W0001209191-21-055341
SEC(opens sec.gov)
Jun 114
Barrett Ronald W0001209191-21-039743
SEC(opens sec.gov)
Jun 124
Barrett Ronald W0001209191-20-036344
SEC(opens sec.gov)
Jun 174
Barrett Ronald W0001209191-19-037563
SEC(opens sec.gov)
Jun 184
Barrett Ronald W0000899243-18-017074
SEC(opens sec.gov)
Dec 64
Barrett Ronald W0001209191-17-064201
SEC(opens sec.gov)

Companies

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130